TGF-beta(1) differentially regulates IL-2 expression and [H-3]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes
Sc. Mckarns et Ne. Kaminski, TGF-beta(1) differentially regulates IL-2 expression and [H-3]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes, IMMUNOPHARM, 48(2), 2000, pp. 101-115
Transforming growth Factor-beta, (TGF-beta(1)) is a critical bifunctional r
egulator of inflammatory responses. Evidence strongly suggests that these r
egulatory consequences are, at least in part, a result of profound pleiotro
pic effects on T lymphocyte effector function. The mechanisms underlying th
e contradictory biological effects of TGF-beta(1) remain ambiguous. The obj
ective of the present studies was to test the hypothesis that the concentra
tion of TGF-beta(1) and the temporal relationship between activation of the
T cell receptor (TCR) and the TGF-beta receptor regulate the effect of TGF
-beta(1) on T lymphocyte activation and proliferation. Toward this end, we
have quantified the concentration- and time-dependent effect of TGF-beta(1)
on interleukin-2 (IL-2) protein secretion as an index of T lymphocyte acti
vation and [H-3]-thymidine incorporation as an index of cell proliferation
in primary splenocytes and thymocytes. Our results suggest that TCF-beta(1)
stimulates IL-2 production at low concentrations (0.1-1 pg/ml) and convers
ely inhibits IL-2 production at high concentrations (1-10 ng/ml) in CD3 eps
ilon monoclonal antibody (mAb) +/- CD28 mAb-activated splenocytes. Addition
ally, concentrations of TGF-beta(1) that simulate IL-2 production in CD3 ep
silon mAb + CD28 mAb-activated splenocytes concominantly inhibit splenocyte
proliferation under similar conditions. Furthermore, we provide evidence s
uggesting that the effects of TGF-beta(1) on T lymphocytes are dependent up
on the temporal relationship between activation of the TCR and the TGF-beta
receptor. A time-dependent loss of a stimulatory effect and a concomitant
gain of an inhibitory response by TGF-beta(1) on IL-2 production in respons
e to CD3 epsilon and CD28 mAbs is observed when TGF-beta(1) is added follow
ing T lymphocyte activation. In summary, these data unequivocally demonstra
te that the orchestration of paradoxical effects of TGF-beta(1) on T-lympho
cyte function is dependent upon the concentration of TGF-beta(1) and the te
mporal relationship between activation of signaling through the TCR and the
TGF-beta receptor. Future mechanistic studies addressing the putative role
that these factors play in modulating the effects of TGF-beta(1).